Ud over at være en potent hæmmer af knogleresorption, har zolendronsyre også adskillige anti- tumor egenskaber der kan bidrage til den samlede effekt i behandling af metastaserende knoglesygdom.
In addition to being a potent inhibitor of bone resorption, zoledronic acid also possesses several anti- tumour properties that could contribute to its overall efficacy in the treatment of metastatic bone disease.